Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

aMoon Fund

Investor type Angel Group
Founders Yair Schindel

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 47
Average round size
info
The average size of a deal this fund participated in
$56M
Portfolio companies 36
Rounds per year 7.83
Lead investments 15
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.23
Exits 3
Key employees 1

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Life Science
Summary

aMoon Fund appeared to be the VC, which was created in 2016. The company was established in Asia in Israel. The main department of described VC is located in the Ra'anana.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the aMoon Fund, startups are often financed by Lightspeed Venture Partners, Elron Electronic Industries, OurCrowd. The meaningful sponsors for the fund in investment in the same round are Lightspeed Venture Partners, Pacific 8 Ventures, OurCrowd. In the next rounds fund is usually obtained by Samsung NEXT, Oxford Finance LLC, Longliv Ventures.

The current fund was established by Yair Schnidel.

Considering the real fund results, this VC is 63 percentage points more often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 2-6 investment rounds annually. The top activity for fund was in 2019.

Among the most successful fund investment fields, there are Medical Device, Big Data. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Israel. The fund has no specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight DayTwo, Medial EarlySign, CartiHeal.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of aMoon Fund:
Typical Co-investors
aMoon Fund is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after aMoon Fund:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Archivist Capital Oregon, Portland, United States
Cinergy Ventures Cincinnati, Ohio, United States
Data Market Services Navarra, Pamplona, Spain
Disney Interactive California, Glendale, United States
Engel Ventures California, Santa Barbara, United States
Homeward Ventures -
Huoer Guosi Chuangtou China, Xinjiang, Yining
Innovation Garden New Jersey, Princeton, United States
Madison Ventures Plus Colorado, Greenwood Village, United States
Ocumension Therapeutics China, Shanghai
P's first Japan, Tokyo
Poland Prize Program -
Renault-Nissan-Mitsubishi Amsterdam, Noord-Holland, The Netherlands
RGM Capital Florida, Naples, United States
Ronghui Capital -
Signum Capital Central, Central Region, Singapore
TX Group Switzerland, Zürich, Zurich
Vanfund Urban Investment & Development Beijing, Beijing, China
Xu Yuan Beijing, Beijing, China
Youyi Investment Management Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Lyfegen

Electronic Health Record (EHR)
Enterprise Software
Health Care
Health Insurance
$8M20 Sep 2022 Basel, Basel-Stadt, Switzerland

Theranica

Biotechnology
Medical
Therapeutics
$45M29 Aug 2022 Israel, North District, Israel

Ultima Genomics

Biotechnology
Health Care
Life Science
Medical
$600M31 May 2022 Newark, California, United States

Eleos Health

Health Care
$20M05 Apr 2022 Cambridge, Massachusetts, United States

PrognomiQ

Biopharma
Biotechnology
Health Care
Medical Device
$46M15 Mar 2022 San Mateo, California, United States

Satellite Bio

Biopharma
Biotechnology
Medical
$82M07 Mar 2022 Cambridge, Massachusetts, United States

MDClone

Health Care
Medical
Medical Device
$63M01 Mar 2022 Beersheba, South District, Israel

Scipher Medicine

Alternative Medicine
Artificial Intelligence
Biotechnology
Health Care
Health Diagnostics
$110M24 Feb 2022 Massachusetts, United States

Omada Health

Health Care
Medical
Therapeutics
Wellness
$192M23 Feb 2022 San Francisco, California, United States
News
Eleos Health Raises $6M in Seed Funding

– Eleos Health is a Boston, MA- and Tel Aviv, Israel-based digital health startup.
– The company closed a $6M seed funding round.
– The round was led by aMoon Fund with participation from lool ventures, and Gandyr Group, alongside Arkin Holdings, Gaingels and former c-suite and executives from Google, MIT Media Lab, and Pegasystems.
– The company intends to use the funds for the expansion of sales, marketing, and solution delivery teams needed to meet the demand for enterprise software deployments across providers and payors.

Amylyx Pharmaceuticals Raises $135M in Series C Financing

– Amylyx Pharmaceuticals, Inc. closed $135m in Series C financing.
Viking Global Investors led the round with participation from Bain Capital Life Sciences, Perceptive Advisors, Rock Springs Capital, Woodline Partners, Marshall Wace, Tybourne Capital Management, Verition Fund Management, aMoon Fund and Falcon Edge.
– The company intends to use the funds for the clinical development and potential launch plans for lead product candidate AMX0035, for the potential treatment of ALS, and further research and development in other neurodegenerative diseases.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent aMoon Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: